We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Proteins Make Reversible Molecular Switch

By Biotechdaily staff writers
Posted on 17 Dec 2004
Nanotechnology researchers have designed a molecular switch by combining two unrelated proteins in a way that causes the response to a specific stimulus by one of the proteins to control the activity of the other.

Investigators at Johns Hopkins University (Baltimore, MD, USA) working with Escherichia coli circularly permuted the gene encoding TEM1 â-lactamase and subsequently randomly inserted it into the gene encoding E coli maltose binding protein. More...
This technique led to the isolation of nearly 27,000 hybrid variations of the two fused proteins. One isolate (RG13) was identified in which its â-lactam hydrolysis activity was inhibited by the absence of maltose but increased 25-fold in its presence. Upon removal of maltose, RG13's catalytic activity returned to the level seen prior to addition of maltose, illustrating that the switching was reversible. These findings were published in the November 2004 issue of Chemistry & Biology.

Senior author Dr. Marc Ostermeier, assistant professor of chemical and biomolecular engineering at Johns Hopkins University, said, "With the new technique, we have produced a molecular switch that is over 10 times more effective. When we introduce this switch into bacteria, it transforms them into a working sensor. We have proven that we can make effective molecular switches. Now, we want to use this idea to create more interesting and more useful devices.”



Related Links:
Johns Hopkins University

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.